Annuaire du laboratoire :

Dr Julie MOUGIN

Ingénieur d’études Nanomédicaments pour le traitement de maladies graves
Site internet: Equipe 7 – NANOMED
Photo de Dr Julie MOUGIN

Informations

CV

In French Julie Mougin est ingénieur diplômée de l’Ecole Nationale Supérieure de Chimie de Mulhouse (ENSMu) et titulaire d’un Master en formulation de systèmes colloïdaux et polymères. Elle a rejoint l’équipe du Prof. Patrick Couvreur au sein de l’Institut Galien Paris-Sud en 2010 an tant qu’Ingénieur d’Etudes. Ses travaux portent sur la caractérisation physico-chimique de nanomédicaments. Elle est actuellement en thèse dont le sujet porte sur la formulation et la caractérisation de nanoassemblages de prodrogues à base de squalène. Elle est co-autrice de 17 publications dans des journaux internationaux à comité de lecture.

In English Julie Mougin is an engineer who graduated from the National College of Chemical Engineering of Mulhouse (ENSMu) and holder of a Master’s degree specialized in formulation of colloids in polymers. She joins the group of Prof. Patrick Couvreur at Institut Galien Paris-Sud in 2010. Her activity is focused on the physico-chemical characterization of nanomedicines. She is also doing a PhD thesis whose topic is about the formulation and the characterization of squalene-based nanoassemblies. She is co-author of 17 publications in international peer-review journals.

Mots clés

In French nanoparticules ; prodrogues ; drug delivery ; physico-chimie ; squalène

In English nanoparticles ; prodrugs ; drug delivery ; physico-chemistry ; squalene

10 publications majeures

  • Kotelevets, L.; Chastre, E.; Caron, J.; Mougin, J.; Bastian, G.; Pineau, A.; Walker, F.; Lehy, T.; Desmaële, D.; Couvreur, P.* A Squalene-Based Nanomedicine for Oral Treatment of Colon Cancer. Cancer Research 2017, DOI : 10.1158/0008-5472.CAN-16-1741
  • Sobot, D.; Mura, S.; Yesylevskyy, S. O.; Dalbin, L.; Cayre, F.; Bort, G.; Mougin, J.; Desmaële, D.; Lepetre-Mouelhi, S.; Pieters, G.; Andreiuk, B.; Klymchenko, A. S.; Paul; J.-L.; Ramseyer, C.; Couvreur, P.* Conjugation of Squalene to Gemcitabine as Unique Approcah Exploiting Endogenous Lipoproteins for Drug Delivery. Nature Communications 2017, DOI : 10.1038/ncomms15678
  • Gaudin, A.; Tagit, O.; Sobot, D.; Lepetre-Moulhi, S.; Mougin, J.; Martens, T. F.; Braeckmans, K.; Nicolas, V.; Desmaële, D.; De Smedt, S.; Hildebrandt, N.; Couvreur, P.;* Andrieux, K. Transport Mechanisms of Squalenoyl-Adenosine Nanoparticles Across the Blood-Brain Barrier. Chemistry of Materials 2015, DOI : 10.1021/acs.chemmater.5b00267
  • Gaudin, A.; Lepetre-Moulhi, S.; Mougin, J.; Parrod, M.; Pieters, G.; Garcia-Argote, S.; Loreau, O.; Goncalves, J.; Chacun, H.; Courtebaisse, Y.; Clayette, P.; Desmaële, D.; Rousseau, B.; Andrieux, K.;* Couvreur, P. Pharmacokinetics, Biodistribution and Metabolism of Squalenoyl Adenosine Nanoparticles in Mice Using Radio-Labelling and Radio-HPLC Analysis. Journal of Controlled Release 2015, DOI : 10.1016/j.jconrel.2015.06.016
  • Gaudin, A.; Yemisci, M.; Eroglu, H.; Lepetre-Moulhi, S.; Turkoglu, O. F.; Dönmez-Demir, B.; Caban, C.; Sargon, M. F.; Garcia-Argote, S.; Pieters, G.; Loreau, O.; Rousseau, B.; Tagit, O.; Hildebrandt, N.; Le Dantec, Y.; Mougin, J.; Valetti, S.; Chacun, H.; Nicolas, V.; Desmaële, D.; Andrieux, K.;* Capan, Y.; Dalkara, T.; Couvreur, P.* Squalenoyl Adenosine Nanoparticles Provide Neuroprotection After Stroke and Spinal Cord Injury. Nature Nanotechnology 2014, DOI : 10.1038/nnano.2014.274
  • Mackiewicz, N.; Nicolas, J.;* Handké, N.; Noiray, M.; Mougin, J.; Daveu, C.; Reddy, L. H.; Bazile, D.; Couvreur, P. Precise Engineering of Multifunctional PEGylated Polyester Nanoparticles for Cancer Cell Targeting and Imaging. Chemistry of Materials 2014, DOI : 10.1021/cm403822w
  • Maksimenko, A.; Alami, M.; Zouhiri, F.; Brion, J.-D.; Pruvost, A.; Mougin, J.; Hamze, A.; Boissenot, T.; Provot, D.; Desmaële, D.; Couvreur, P.* Therapeutic Modalities of Squalenoyl Nanocomposites in Colon Cancer: an Ongoing Search for Improved Efficacy. ACS Nano 2014, DOI : 10.1021/nn500517a
  • Maksimenko, A.; Dosio, F.; Mougin, J.; Ferrero, A.; Wack, S.; Reddy, L. H.; Weyn, A.-A.; Lepeltier, E.; Bourgaux, C.; Stella, B.; Cattel, L.; Couvreur, P.* A Unique Squalenoylated and Nonpegylated Doxorubicine Nanomedicine with Systemic Long-Circulating Properties and Anticancer Activity. Proceedings of the National Academy of Sciences 2014, DOI : 10.1073/pnas.1313459110
  • Harrisson, S.; Nicolas, J.;* Maksimenko, A.; Bui, D. T.; Mougin, J.; Couvreur, P. Nanoparticles with In Vivo Anticancer Activity from Polymer Prodrug Amphiphiles Prepared by Living Radical Polymerization. Angewandte Chemie 2013, DOI : 10.1002/anie.201207297
  • Maksimenko, A.; Mougin, J.; Mura, S.; Sliwinski, E.; Lepeltier, E.; Bourgaux, C.; Lepetre-Moulhi, S.; Zouhiri, F.; Desmaële, D.; Couvreur, P.* Polyisoprenoyl Gemcitabine Conjugates Self Assemble as Nanoparticles, Useful for Cancer Therapy. Cancer Letters 2013, DOI : 10.1016/j.canlet.2012.08.023


15 documents

  • Chen Zhu, Hannah Beauseroy, Julie Mougin, Maëlle Lages, Julien Nicolas. In situ synthesis of degradable polymer prodrug nanoparticles. Chemical Science, 2025, 16 (6), pp.2619-2633. ⟨10.1039/D4SC07746F⟩. ⟨hal-04927251⟩
  • Hadjer Hazam, Lucas Prades, Catherine Cailleau, Julie Mougin, Jiao Feng, et al.. A nanomedicine approach for the treatment of long-lasting pain. Journal of Controlled Release, 2024, 373, pp.688-698. ⟨10.1016/j.jconrel.2024.07.033⟩. ⟨hal-04927256⟩
  • Julie Mougin, Claudie Bourgaux, Patrick Couvreur. Elongated self-assembled nanocarriers: From molecular organization to therapeutic applications. Advanced Drug Delivery Reviews, 2021, 172, pp.127-147. ⟨10.1016/j.addr.2021.02.018⟩. ⟨hal-04355517⟩
  • Julie Mougin. Contribution to physico-chemical studies of squalenoylated nanomedicines for cancer treatment. Theoretical and/or physical chemistry. Université Paris-Saclay, 2020. English. ⟨NNT : 2020UPASS038⟩. ⟨tel-02885220⟩
  • Julie Mougin, Semen Yesylevskyy, Claudie Bourgaux, David Chapron, Jean-Philippe Michel, et al.. Stacking as a key property for creating nanoparticles with tunable shape: The case of Squalenoyl-doxorubicin. ACS Nano, 2019, 13 (11), pp.12870-12879. ⟨10.1021/acsnano.9b05303⟩. ⟨hal-04594918⟩
  • Larissa Kotelevets, Eric Chastre, Joachim Caron, Julie Mougin, Gerard Bastian, et al.. A Squalene-Based Nanomedicine for Oral Treatment of Colon Cancer. Cancer Research, 2017, 77 (11), pp.2964-2975. ⟨10.1158/0008-5472.CAN-16-1741⟩. ⟨hal-04927300⟩
  • Eric Buchy, Gizem Askin, Fanny Cayre, Julie Mougin, Sandrine Gouazou, et al.. In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better. Biochimie, 2016, 130, pp.4-13. ⟨10.1016/j.biochi.2016.08.003⟩. ⟨hal-04927305⟩
  • Nadia Abed, Fatouma Saïd-Hassane, Fatima Zouhiri, Julie Mougin, Valérie Nicolas, et al.. An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance. Scientific Reports, 2015, 5 (1), pp.13500. ⟨10.1038/srep13500⟩. ⟨hal-04927313⟩
  • Andrei Maksimenko, Joachim Caron, Julie Mougin, Didier Desmaele, P Couvreur. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies. International Journal of Pharmaceutics, 2015, 482 (1-2), pp.38-46. ⟨10.1016/j.ijpharm.2014.11.009⟩. ⟨hal-04927324⟩
  • Eric Buchy, Sabrina Valetti, Julie Mougin, Claire Troufflard, Simona Mura, et al.. Synthesis and Cytotoxic Activity of Self‐Assembling Squalene Conjugates of 3‐[(Pyrrol‐2‐yl)methylidene]‐2,3‐dihydro‐1 H ‐indol‐2‐one Anticancer Agents. European Journal of Organic Chemistry, 2015, 2015 (1), pp.202-212. ⟨10.1002/ejoc.201403088⟩. ⟨hal-04927326⟩

 

 

Catégories : Equipe 7 : Nanomédicaments pour le traitement de maladies graves
Mis à jour il y a 11 mois.